A case for treating high hepatitis B DNA levels before starting HIV therapy
- 28 November 2006
- journal article
- other
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (18) , 2402-2403
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudineJournal of Viral Hepatitis, 2006
- Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA LevelJAMA, 2006
- Treatment of Chronic Hepatitis B in HIV-Infected Persons: Thinking Outside the Black BoxClinical Infectious Diseases, 2005
- Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in FranceAIDS, 2005
- EntecavirNature Reviews Drug Discovery, 2005
- Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohortAIDS, 2005
- Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International PanelAIDS, 2005
- Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapyAIDS, 2005
- Immune Reconstitution Hepatitis in HIV and Hepatitis B Coinfection, Despite Lamivudine Therapy as Part of HAARTClinical Infectious Diseases, 2004
- Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitorThe Lancet, 1997